Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+4.4%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$168M |
| 2 |
Apple
AAPL
|
$71.3M |
| 3 |
Microsoft
MSFT
|
$57.4M |
| 4 |
HDFC Bank
HDB
|
$44.6M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
$40.5M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$83.3M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$81.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$43.3M |
| 4 |
Broadcom
AVGO
|
$42.7M |
| 5 |
Advanced Micro Devices
AMD
|
$37.7M |
Sector Composition
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Personalis
PSNL
$466M
| $13.8K | ﹤0.01% |
+2,354
| New | +$13.8K |
|
1477
Codexis
CDXS
$218M
| $13.5K | ﹤0.01% |
+2,712
| New | +$13.5K |
|
1478
nCino
NCNO
$3.52B
| $13.5K | ﹤0.01% |
402
-71
| -15% | -$2.38K |
|
|
UHT
1479
Universal Health Realty Income Trust
UHT
$574M
| $13.4K | ﹤0.01% |
367
-143
| -28% | -$5.23K |
|
1480
Marathon Digital Holdings
MARA
$5.63B
| $13.3K | ﹤0.01% |
791
-140
| -15% | -$2.35K |
|
|
GMRE
1481
Global Medical REIT
GMRE
$508M
| $13.2K | ﹤0.01% |
1,739
-679
| -28% | -$5.17K |
|
1482
AnaptysBio
ANAB
$612M
| $13.2K | ﹤0.01% |
1,014
-78
| -7% | -$1.02K |
|
1483
Payoneer
PAYO
$2.4B
| $12.9K | ﹤0.01% |
1,285
-228
| -15% | -$2.29K |
|
|
OLP
1484
One Liberty Properties
OLP
$511M
| $12.8K | ﹤0.01% |
476
-186
| -28% | -$4.98K |
|
1485
Galapagos
GLPG
$2.2B
| $12.7K | ﹤0.01% |
465
-268
| -37% | -$7.32K |
|
|
ALMS
1486
Alumis Inc. Common Stock
ALMS
$468M
| $12.7K | ﹤0.01% |
+1,574
| New | +$12.7K |
|
|
ALX
1487
Alexander's
ALX
$1.2B
| $12.7K | ﹤0.01% |
64
-25
| -28% | -$4.96K |
|
1488
Prime Medicine
PRME
$661M
| $12.7K | ﹤0.01% |
4,371
+30
| +0.7% | +$87 |
|
|
CLDT
1489
Chatham Lodging
CLDT
$362M
| $12.3K | ﹤0.01% |
1,365
-533
| -28% | -$4.79K |
|
1490
Regenxbio
RGNX
$490M
| $12.2K | ﹤0.01% |
1,651
-137
| -8% | -$1.02K |
|
1491
Sana Biotechnology
SANA
$752M
| $12K | ﹤0.01% |
7,440
-606
| -8% | -$976 |
|
1492
Taysha Gene Therapies
TSHA
$914M
| $12K | ﹤0.01% |
6,829
-583
| -8% | -$1.02K |
|
1493
Y-mAbs Therapeutics
YMAB
$390M
| $11.9K | ﹤0.01% |
1,493
-119
| -7% | -$952 |
|
1494
Design Therapeutics
DSGN
$368M
| $11.8K | ﹤0.01% |
+1,887
| New | +$11.8K |
|
1495
Olema Pharmaceuticals
OLMA
$572M
| $11.7K | ﹤0.01% |
1,909
-162
| -8% | -$996 |
|
1496
Neurogene
NGNE
$285M
| $11.4K | ﹤0.01% |
+495
| New | +$11.4K |
|
|
SAGE
1497
DELISTED
Sage Therapeutics
SAGE
| $11.3K | ﹤0.01% |
2,039
-169
| -8% | -$936 |
|
|
PKST
1498
Peakstone Realty Trust
PKST
$500M
| $11.2K | ﹤0.01% |
1,015
-396
| -28% | -$4.38K |
|
1499
Vertex
VERX
$3.83B
| $11.2K | ﹤0.01% |
210
-42
| -17% | -$2.24K |
|
1500
Tango Therapeutics
TNGX
$773M
| $11.2K | ﹤0.01% |
3,580
-295
| -8% | -$920 |
|